Effect of anticoagulant therapy on the course of COVID-19 in comorbid patients-Reference-Cited by-同舟云学术

Effect of anticoagulant therapy on the course of COVID-19 in comorbid patients

Published:2021-03-07 Issue:1 Volume:66 Page:40-46
ISSN:2411-2097
Container-title:Problems of Virology
language:
Short-container-title:Voprosy virusologii

Author:

Ruzhentsova T. A.¹^ORCID,Khavkina D. A.²^ORCID,Chukhliaev P. V.²^ORCID,Garbuzov A. A.²^ORCID,Ploskireva A. A.²^ORCID

Affiliation:

1. FSBI Gabrichevsky research institute for epidemiology and microbiology of the Surveillance of Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor)

2. FSBI Central Research Institute for Epidemiology of the Surveillance of Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor)

Publisher

Central Research Institute for Epidemiology

Subject

Infectious Diseases,Virology,General Medicine

Reference5 articles.

1. Paranjpe I., Fuster V, LalaA., RussakA.J., Glicksberg B.S., Levin M.A., et al. Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J. Am. Coll. Cardiol. 2020; 76(1): 122-9. https://doi.org/10.1016/).jacc.2020.05.001.

2. Lillicrap D. Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia. J. Thromb. Haemost. 2020; 18(4): 786-7. https://doi.org/10.1111/jth.14781.

3. Tang N., Bai H., Chen X., Gong J., Li D., Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavi-rus disease 2019 patients with coagulopathy. J. Thromb. Haemost. 2020; 18(5): 1094-9. https://doi.org/10.1111/jth.14817.

4. Wu J., Liu J., Zhao X., Liu C., Wang W., Wang D., et al. Clinical characteristics of imported cases of COVID-19 in Jiangsu Province: A multicenter descriptive study. Clin. Infect. Dis. 2020; 71(15): 706-12. https://doi.org/10.1093/cid/ciaa199.

5. Steffel J., Verhamme P., Potpara T.S., Albaladejo P., Antz M., Desteghe L., et al. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur. Heart J. 2018; 39(16): 1330-93. https://doi.org/10.1093/eurheartj/ehy136.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticoagulant use before COVID-19 diagnosis prevent COVID-19 associated acute venous thromboembolism or not: A systematic review and meta-analysis;World Journal of Methodology;2024-09-20

2. Optimal choice of indicators for timely assessment of the prognosis of COVID-19 in hospitalized patients;HIV Infection and Immunosuppressive Disorders;2024-09-06

3. Direct Oral Anticoagulants’ Consumption and Expenditure in the COVID-19 Pandemic in Russia and Clinical Practice Guidelines for Their Use;Pharmacoepidemiology;2023-12-29

4. Factors associated with adverse outcome among hospitalized patients with moderate to severe COVID-19;Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice;2023-04-19

5. Issues of etiotropic therapy in conditions of ‘omicron’ strain of SARS-CoV‑2 spreading: Real practice;Medical alphabet;2022-07-26